|
1
|
Brem H and Tomic-Canic M: Cellular and
molecular basis of wound healing in diabetes. J Clin Invest.
117:1219–1222. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Galiano RD, Tepper OM, Pelo CR, et al:
Topical vascular endothelial growth factor accelerates diabetic
wound healing through increased angiogenesis and by mobilizing and
recruiting bone marrow-derived cells. Am J Pathol. 164:1935–1947.
2004. View Article : Google Scholar
|
|
3
|
Falanga V: Wound healing and its
impairment in the diabetic foot. Lancet. 366:1736–1743. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Singer AJ and Clark RA: Cutaneous wound
healing. N Engl J Med. 341:738–746. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Velazquez OC: Angiogenesis and
vasculogenesis: inducing the growth of new blood vessels and wound
healing by stimulation of bone marrow-derived progenitor cell
mobilization and homing. J Vasc Surg. 45(Suppl A): A39–A47. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chan RK, Liu PH, Pietramaggiori G, et al:
Effect of recombinant platelet-derived growth factor (Regranex) on
wound closure in genetically diabetic mice. J Burn Care Res.
27:202–205. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ackermann M, Wolloscheck T, Wellmann A, et
al: Priming with a combination of proangiogenic growth factors
improves wound healing in normoglycemic mice. Int J Mol Med.
27:647–653. 2011.PubMed/NCBI
|
|
8
|
Ackermann M, Wolloscheck T, Wellmann A, et
al: Priming with a combination of proangiogenic growth factors
Enhances wound healing in streptozotocin-induced diabetes in mice.
Eur Surg Res. 47:81–89. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Asahara T, Murohara T, Sullivan A, et al:
Isolation of putative progenitor endothelial cells for
angiogenesis. Science. 275:964–967. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kawamoto A, Gwon HC, Iwaguro H, et al:
Therapeutic potential of ex vivo expanded endothelial progenitor
cells for myocardial ischemia. Circulation. 103:634–637. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Rafii S and Lyden D: Therapeutic stem and
progenitor cell transplantation for organ vascularization and
regeneration. Nat Med. 9:702–712. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Patschan D, Krupincza K, Patschan S, et
al: Dynamics of mobilization and homing of endothelial progenitor
cells after acute renal ischemia: modulation by ischemic
preconditioning. Am J Physiol Renal Physiol. 291:F176–F185. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Galiano RD, Tepper OM, Pelo CR, et al:
Topical vascular endothelial growth factor accelerates diabetic
wound healing through increased angiogenesis and by mobilizing and
recruiting bone marrow-derived cells. Am J Pathol. 164:1935–1947.
2004. View Article : Google Scholar
|
|
14
|
Sivan-Loukianova E, Awad OA, et al:
CD34+blood cells accelerate vascularization and healing
of diabetic mouse skin wounds. J Vasc Res. 40:368–377. 2003.
|
|
15
|
Rafii S and Lyden D: Therapeutic stem and
progenitor cell transplantation for organ vascularization and
regeneration. Nat Med. 9:702–712. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Urbich C and Dimmeler S: Endothelial
progenitor cells: characterization and role in vascular biology.
Circ Res. 95:343–353. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yoon CH, Hur J, Oh IY, et al:
Intercellular adhesion molecule-1 is upregulated in ischemic
muscle, which mediates trafficking of endothelial progenitor cells.
Arterioscler Thromb Vasc Biol. 26:1066–1072. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Asahara T, Takahashi T, Masuda H, et al:
VEGF contributes to postnatal neovascularization by mobilizing bone
marrow-derived endothelial progenitor cells. EMBO J. 18:3964–3972.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Shi Q, Bhattacharya V, Hong-De Wu M and
Sauvage LR: Utilizing granulocyte colony-stimulating factor to
enhance vascular graft endothelialization from circulating blood
cells. Ann Vasc Surg. 16:314–320. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Takahashi T, Kalka C, Masuda H, et al:
Ischemia- and cytokine-induced mobilization of bone marrow-derived
endothelial progenitor cells for neovascularization. Nat Med.
5:434–438. 1999. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Luttun A, Tjwa M and Carmeliet P:
Placental growth factor (PlGF) and its receptor Flt-1 (VEGFR-1):
novel therapeutic targets for angiogenic disorders. Ann NY Acad
Sci. 979:80–93. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ziebart T, Yoon CH, Trepels T, et al:
Sustained persistence of transplanted proangiogenic cells
contributes to neovascularization and cardiac function after
ischemia. Circ Res. 103:1327–1334. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ziebart T, Pabst A, Klein MO, et al:
Bisphosphonates: restrictions for vasculogenesis and angiogenesis:
inhibition of cell function of endothelial progenitor cells and
mature endothelial cells in vitro. Clin Oral Investig. 15:105–111.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lenzen S: The mechanisms of alloxan- and
streptozotocin-induced diabetes. Diabetologia. 51:216–226. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Weibel ER, Kistler GS and Scherle WF:
Practical stereological methods for morphometric cytology. J Cell
Biol. 30:23–38. 1966. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Erba P, Miele LF, Adini A, et al: A
morphometric study of mechanotransductively induced dermal
neovascularization. Plast Reconstr Surg. 128:288e–299e. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hendrickx B, Den Hondt M, Verdonck K,
Vranckx JJ and Luttun A: Cell and Gene Transfer Strategies for
Vascularization During Skin Wound Healing. Emerging Trends in Cell
and Gene Therapy. Danquah MK and Mahato RI: Humana Press; New York,
NY: pp. 637–695. 2013, View Article : Google Scholar
|
|
28
|
Smiell JM, Wieman TJ, Steed DL, et al:
Efficacy and safety of becaplermin (recombinant human
platelet-derived growth factor-BB) in patients with nonhealing,
lower extremity diabetic ulcers: a combined analysis of four
randomized studies. Wound Repair Regen. 7:335–346. 1999. View Article : Google Scholar
|
|
29
|
Sander AL, Jakob H, Henrich D, et al:
Systemic transplantation of progenitor cells accelerates wound
epithelialization and neovascularization in the hairless mouse ear
wound model. J Surg Res. 165:165–170. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Gallagher KA, Liu ZJ, Xiao M, et al:
Diabetic impairments in NO-mediated endothelial progenitor cell
mobilization and homing are reversed by hyperoxia and SDF-1 alpha.
J Clin Invest. 117:1249–1259. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
31
|
Liu ZJ and Velazquez OC: Hyperoxia,
endothelial progenitor cell mobilization, and diabetic wound
healing. Antioxid Redox Signal. 10:1869–1882. 2008. View Article : Google Scholar : PubMed/NCBI
|
